GREM1 and diabetic kidney disease: Therefore, a blockade of VEGFR2 signaling in the kidney could exert anti-inflammatory and anti-fibrotic effects by targeting GREMLIN actions in tubular cells, as described in other experimental models of renal injury, such as unilateral ureteral obstruction [51], and extended here to experimental diabetic nephropathy.